DOTATATE (Ga-68)
Overview
Gallium-68 DOTATATE is a radiolabeled somatostatin analog consisting of an octapeptide (Tyr3-octreotate) conjugated to the macrocyclic chelator DOTA, which binds the positron-emitting radioisotope gallium-68. It exhibits high affinity for somatostatin receptor subtype 2, which is overexpressed on neuroendocrine tumor cells, enabling PET imaging of these malignancies.
Mechanism of Action
The 68-minute half-life of gallium-68 and the rapid pharmacokinetics of the peptide provide excellent tumor-to-background ratios within 1 to 2 hours post-injection.
Research Summary & Key Findings
The FDA approved gallium-68 DOTATATE (Netspot) in June 2016 for PET imaging of somatostatin receptor-positive neuroendocrine tumors based on studies demonstrating superior lesion detection compared to conventional imaging modalities including octreotide scintigraphy. A prospective multicenter trial published in the Journal of Nuclear Medicine (2013) showed 95.1% sensitivity for neuroendocrine tumor detection.
Clinical Status
DOTATATE (Ga-68) has received FDA approval and is available for clinical use under appropriate medical supervision. Consult a qualified healthcare provider for prescribing information.
Administration Routes
References
Primary literature
- PubMed — "DOTATATE"
Peer-reviewed literature indexed by the National Library of Medicine.
- ClinicalTrials.gov — "DOTATATE"
Registered interventional and observational studies, including status and phase.
- PubChem — "DOTATATE"
Chemical structure, molecular properties, and bioactivity data.
Study-level citations for this compound are being verified against the primary sources before publication. The database queries above return the current indexed literature in the meantime.
Related Peptides in Diagnostic
Pentagastrin
FDA ApprovedA synthetic pentapeptide containing the C-terminal tetrapeptide sequence of gastrin (Trp-Met-Asp-Phe-NH2) linked to beta...
View detailsGadopentetate Peptide Conjugates
Research PhaseGadopentetate peptide conjugates consist of the gadolinium-based contrast agent gadopentetate dimeglumine chemically lin...
View detailsBombesin Analog Tracers
In Clinical TrialsBombesin analog tracers are synthetic peptides based on the 14-amino acid amphibian peptide bombesin or its mammalian co...
View detailsRGD Peptide Tracers
In Clinical TrialsRGD peptide tracers are short synthetic peptides containing the arginine-glycine-aspartic acid (RGD) tripeptide sequence...
View detailsStart Your Consultation
Get an AI-proposed DOTATATE (Ga-68) protocol reviewed by a physician in our network.
Start Your ConsultationFind a Pharmacy
Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply DOTATATE (Ga-68).
Pharmacy DirectoryJoin the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol. See our editorial policy for how this content is produced and reviewed.